These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26046473)

  • 1. Development and Validation of the Simplified Chinese Version of EORTC QLQ-HCC18 for Patients with Hepatocellular Carcinoma.
    Yang Z; Wan C; Li W; Cun Y; Meng Q; Ding Y; Chen P
    Cancer Invest; 2015; 33(8):340-6. PubMed ID: 26046473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Japanese version of the EORTC hepatocellular carcinoma-specific quality of life questionnaire module (QLQ-HCC18).
    Mikoshiba N; Tateishi R; Tanaka M; Sakai T; Blazeby JM; Kokudo N; Koike K; Kazuma K
    Health Qual Life Outcomes; 2012 May; 10():58. PubMed ID: 22651810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric validation of the EORTC QLQ-HCC18 in patients with previously treated unresectable hepatocellular carcinoma.
    Serrano D; Podger L; Barnes G; Song J; Tang B
    Qual Life Res; 2022 Mar; 31(3):937-950. PubMed ID: 34518988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18.
    Chie WC; Blazeby JM; Hsiao CF; Chiu HC; Poon RT; Mikoshiba N; Al-Kadhimi G; Heaton N; Calara J; Collins P; Caddick K; Costantini A; Vilgrain V; Trinquart L; Chiang C;
    Hepatology; 2012 Apr; 55(4):1122-9. PubMed ID: 22105642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a simplified chinese version of EORTC QLQ-CR38 to measure the quality of life of patients with colorectal cancer.
    Kong D; Yang Z; Wang Y; Meng Q; Tang X; Cun Y; Wan C
    Oncology; 2012; 83(4):201-9. PubMed ID: 22890104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability, validity and responsiveness of the Mandarin (Simplified) Chinese version of the EORTC QLQ-OH45 among cancer patients.
    Liu J; Gao J; Wu CX; Bai DX; Li X; Guo XX; Yu JY; Xiao QQ; Bao XR; He LC; Zhong YZ; Chen S
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12987. PubMed ID: 30614580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of the simplified Chinese version of EORTC QLQ-H&N35 for patients with head and neck cancer.
    Yang Z; Meng Q; Luo J; Lu Q; Li X; Li G; Wan C
    Support Care Cancer; 2012 Jul; 20(7):1555-64. PubMed ID: 21850417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
    Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
    BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study to validate the Polish language version of the European Organisation for Research and Treatment of Cancer (EORTC) Colorectal Liver Metastases (QLQ-LMC21) module.
    Paradowska D; Bereza K; Sanna B; Kucharska E; Tomaszewska IM; Dudkiewicz Z; Skotnicki P; Bottomley A; Tomaszewski KA
    Eur J Oncol Nurs; 2017 Aug; 29():148-154. PubMed ID: 28578847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in health-related quality of life between European and Asian patients with hepatocellular carcinoma.
    Chie WC; Blazeby JM; Hsiao CF; Chiu HC; Poon RT; Mikoshiba N; Al-Kadhim G; Heaton N; Calara J; Collins P; Caddick K; Costantini A; Vilgrain V;
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e304-e311. PubMed ID: 27038366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Questionnaire to assess quality of life in patients with breast cancer - Validation of the Chinese version of the EORTC QLQ-BR 53.
    Zhang Z; Zhang X; Wei L; Lin Y; Wu D; Xie S; Yue L; Tian J; Zhang Y; Song Q; Woo SM; Miller AR; Luo L; Zhang L
    Breast; 2017 Apr; 32():87-92. PubMed ID: 28068605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric properties of the simplified Chinese version of the EORTC QLQ-BR53 for measuring quality of life for breast cancer patients.
    Wan C; Tang X; Tu XM; Feng C; Messing S; Meng Q; Zhang X
    Breast Cancer Res Treat; 2007 Oct; 105(2):187-93. PubMed ID: 17221159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the simplified Chinese version of the quality of life instrument EORTC QLQ-LC43 for patients with lung cancer.
    Wan C; Zhang C; Tu X; Feng C; Tang W; Luo J; Meng Q
    Cancer Invest; 2008 Jun; 26(5):504-10. PubMed ID: 18568773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancer.
    Wan C; Meng Q; Yang Z; Tu X; Feng C; Tang X; Zhang C
    Ann Oncol; 2008 Dec; 19(12):2053-60. PubMed ID: 18653703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
    Blazeby JM; Currie E; Zee BC; Chie WC; Poon RT; Garden OJ;
    Eur J Cancer; 2004 Nov; 40(16):2439-44. PubMed ID: 15519517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients.
    Li L; Chan SL; Mo F; Hui EP; Koh J; Chan AK; Tang NL; Chu CM; Hui J; Lee KF; Yu S; Yeo W
    Qual Life Res; 2019 Sep; 28(9):2597-2607. PubMed ID: 31037590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Chinese version of EORTC QLQ-BN20 for patients with brain cancer.
    Zhang K; Tian J; He Z; Sun W; Pekbay B; Lin Y; Wu D; Zhang J; Chen P; Guo H; Wan Y; Wang M; Yang S; Zheng J; Zhang L
    Eur J Cancer Care (Engl); 2018 Mar; 27(2):e12832. PubMed ID: 29461664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prospective Evaluation of the Reliability and Utility of Quality of Life Measures in Patients With Hepatocellular Carcinoma.
    Kim GA; Kim HI; Chang S; An J; Lee D; Lee HC; Han S; Shim JH
    Am J Clin Oncol; 2019 Jul; 42(7):555-563. PubMed ID: 31135382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation and validation of Sinhala version of modified EORTC QLQ-OH15 in oral cancer patients who receive radiotherapy with or without chemotherapy in Sri Lanka.
    Kosgallana S; Jayasekara P; Abeysinghe P; Hjermstad M; Lalloo R
    BMC Oral Health; 2022 Aug; 22(1):359. PubMed ID: 35986341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer.
    Lin JB; Zhang L; Wu DW; Xi ZH; Wang XJ; Lin YS; Fujiwara W; Tian JR; Wang M; Peng P; Guo A; Yang Z; Luo L; Jiang LY; Li QQ; Zhang XY; Zhang YF; Xu HW; Yang B; Li XL; Lei YX
    World J Gastroenterol; 2017 Mar; 23(10):1891-1898. PubMed ID: 28348496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.